<DOC>
	<DOCNO>NCT01506362</DOCNO>
	<brief_summary>The objective propose study determine whether BL-7040 demonstrate clinical efficacy patient inflammatory bowel disease ( IBD ) .</brief_summary>
	<brief_title>Efficacy , Pharmacodynamics , Safety Tolerability Oral BL-7040 Patients With Moderately Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . Male female , age 18 70 . 2 . Moderately active ulcerative colitis define Mayo score ≥ 5 ≤ 9 within 9 day first day study treatment . 3 . Diagnosis ulcerative colitis ≥ 3 month prior study entry . 4 . Endoscopic subscore ≥ 2 rectal bleed subscore ≥ 1 Mayo score endoscopic evidence disease activity minimum 20 cm anal verge , determine within 9 day first day study treatment . 5 . Female patient must negative serum pregnancy test screen willing able use medically acceptable method birth control declare abstain sexual intercourse , screen visit study termination visit surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) postmenopausal . Postmenopausal woman define woman menstruation cessation 12 consecutive month prior sign inform consent form . 6 . Ability willingness understand comply study procedure give write informed consent prior enrollment 1 . Diagnosis indeterminate colitis clinical finding suggestive Crohn 's disease . 2 . Subjects ulcerative proctitis . 3 . A diagnosis ischemic colitis , fulminant colitis toxic megacolon . 4 . Evidence bowel infection . 5 . Body temperature ≥ 38°C screening . 6 . Evidence abdominal abscess initial screen visit . 7 . Extensive colonic resection , subtotal total colectomy . 8 . Ileostomy , colostomy , know fix symptomatic stenosis intestine . 9 . Receiving nonpermitted IBD therapy 10 . History current peptic ulcer disease . 11 . Pregnant lactating woman . 12 . Chronic hepatitis B C infection HIV seropositivity . 13 . Current recent history severe , progressive , uncontrolled renal , hepatic , hematological , gastrointestinal , metabolic , endocrine , pulmonary , cardiac neurological disease . 14 . Drug alcohol abuse ( history ) . 15 . Patients participate clinical trial . 16 . Patients inability communicate well Investigators staff ( i.e. , language problem , poor mental development impair cerebral function ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>IBD</keyword>
</DOC>